DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Borel-Derlon A, Federici AB, Roussel-Robert V. , et al.
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50 patients.
J Thromb Haemost 2007;
5 (06) 1115-1124
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.